×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
Yahoo Finance
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript May 9, 2024 Clearside Biomedical, Inc. isn't one of the 30 most...
2 weeks ago
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space ...
GlobeNewswire
Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery...
6 days ago
Clearside Biomedical prices $15M offering
Drug Delivery Business
Clearside Biomedical (Nasdaq:CLSD) announced that it entered into a securities purchase agreement worth proceeds of approximately $15...
3 months ago
Clearside announces publication of guidelines for drug delivery via SCS - TipRanks.com
Tipranks
Clearside Biomedical announced that RETINA, The Journal of Retinal and Vitreous Diseases, has published new guidelines that represent best practices for...
5 days ago
Clearside Biomedical Announces First Quarter 2024 Financial Results
Vision Monday
ALPHARETTA, Ga.—Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing treatments that restore and preserve vision...
2 weeks ago
Clearside Biomedical (NASDAQ:CLSD) Share Price Passes Below Fifty Day Moving Average of $1.40
Defense World
Read Clearside Biomedical (NASDAQ:CLSD) Share Price Passes Below Fifty Day Moving Average of $1.40 at Defense World.
5 days ago
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying - Clearside Biomedical (NASDAQ:CLSD)
Benzinga
The Dow Jones index closed higher by around 350 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or...
2 weeks ago
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Yahoo Finance
Industry Veteran with Extensive Experience in Retinal Disease Research and Strong Track Record in Advancing Programs Through Clinical...
2 months ago
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
Phase 2b ODYSSEY Trial in Wet AMD Remains on Track with Topline Data Expected Q3 2024 - - Strengthened Management Team and Board of...
2 weeks ago
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May ...
Yahoo Finance
ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing...
1 month ago